Jazz Pharmaceuticals Plc · NASDAQ:JAZZ

Smith Mark Douglas sold 1,157 Jazz Pharmaceuticals Plc shares (Form 4)

Traded Jun 15, 2026 · Filed Jun 17, 2026

On Jun 15, 2026, Smith Mark Douglas (Director) sold 1,157 Jazz Pharmaceuticals Plc shares at US$230.55 for US$267K under a trading plan, leaving 9,680 shares. Filed Jun 17, 2026 (Form 4).

Sold
1,157 shares
Price
US$230.55
Value
US$267K
Holding after
9,680 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 15, 2026Ordinary SharesSale1,157US$230.559,680Direct

Source

View original at SEC

Related